APRI (Aprinoia Therapeutics) Accumulated Depreciation: $-0.87 Mil (As of Dec. 2023)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Aprinoia Therapeutics Accumulated Depreciation?

Aprinoia Therapeutics APRI Accumulated Depreciation is $-0.87 Mil as of Dec. 2023.

Note: A negative number here means the assets are depreciated. When depricates more, the absolute value gets bigger.

Aprinoia Therapeutics's quarterly accumulated depreciation declined from Dec. 2022 ($-0.49 Mil) to Jun. 2023 ($0.00 Mil) but then increased from Jun. 2023 ($0.00 Mil) to Dec. 2023 ($-0.87 Mil).

Aprinoia Therapeutics's annual accumulated depreciation increased from Dec. 2021 ($-0.21 Mil) to Dec. 2022 ($-0.49 Mil) and increased from Dec. 2022 ($-0.49 Mil) to Dec. 2023 ($-0.87 Mil).

Aprinoia Therapeutics Accumulated Depreciation Related Terms

Aprinoia Therapeutics Accumulated Depreciation Historical Data

* Premium members only.

The historical data trend for Aprinoia Therapeutics's Accumulated Depreciation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Aprinoia Therapeutics Accumulated Depreciation Chart

Aprinoia Therapeutics Annual Data
Trend Dec21 Dec22 Dec23
Accumulated Depreciation
-0.21 -0.49 -0.87

Aprinoia Therapeutics Semi-Annual Data
Dec21 Jun22 Dec22 Jun23 Dec23
Accumulated Depreciation -0.21 0.00 -0.49 0.00 -0.87

Aprinoia Therapeutics Accumulated Depreciation Calculation

The cumulative depreciation of an asset up to a single point in its life. Regardless of the method used to calculate it, the depreciation of an asset during a single period is added to the previous period's accumulated depreciation to get the current accumulated depreciation.

What does a Accumulated Depreciation of $-0.87 Mil mean?
Aprinoia Therapeutics (APRI) has a Accumulated Depreciation of $-0.87 Mil as of Dec. 2023. Accumulated depreciation is a contra-asset item that accounts for the decline in value of long-term assets. View historical data on Aprinoia Therapeutics and its competitors.
Is Aprinoia Therapeutics' Accumulated Depreciation too high?
Aprinoia Therapeutics' current Accumulated Depreciation is $-0.87 Mil.
How does Aprinoia Therapeutics' Accumulated Depreciation compare to ?
Aprinoia Therapeutics' Accumulated Depreciation of $-0.87 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Accumulated Depreciation for a Biotechnology company?
A good Accumulated Depreciation depends on the Biotechnology industry context. However, Accumulated Depreciation should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Accumulated Depreciation mean?
A high Accumulated Depreciation can signal that a stock is expensive relative to its fundamentals. Accumulated depreciation is a contra-asset item that accounts for the decline in value of long-term assets. View historical data on Aprinoia Therapeutics and its competitors. Aprinoia Therapeutics's current Accumulated Depreciation is $-0.87 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Aprinoia Therapeutics stock overvalued right now?
Aprinoia Therapeutics (APRI) has a current Accumulated Depreciation of $-0.87 Mil. The current Accumulated Depreciation is $-0.87 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Accumulated Depreciation calculated?
Accumulated Depreciation is calculated from a company's financial statements. For Aprinoia Therapeutics (APRI), the current Accumulated Depreciation is $-0.87 Mil as of Dec. 2023. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Aprinoia Therapeutics Business Description

Comparable Companies
Address 245 Main Street, 2nd Floor, Cambridge, MA, USA, 02142
Aprinoia Therapeutics Inc is a clinical-stage biotechnology company. It is engaged in protecting patients' brain health and changing clinical outcomes for a broad range of neurodegenerative diseases by developing novel, highly sensitive and selective diagnostic tools and novel therapeutics. Neurodegenerative diseases are relentless and largely fatal, resulting from progressive loss of nerve cells in the brain and, depending on the specific disorders, can affect a broad range of cognitive, behavioral, and motor functions, such as memory, thinking, speaking, walking, and breathing. It is developing several different diagnostic and therapeutic platforms such as abnormal protein aggregates of tau and alpha synuclein ("?-Syn") that are toxic to brain cells.